Zobrazeno 1 - 6
of 6
pro vyhledávání: '"on behalf of the Hellenic Sepsis Study Group"'
Autor:
George Dimοpoulos, Nikoletta Rovina, Maria Patrani, Eleni Antoniadou, Dimitrios Konstantonis, Konstantina Vryza, Glykeria Vlachogianni, Miltiades Kyprianou, Christina Routsi, Evangelos J. Giamarellos-Bourboulis, on behalf of the Hellenic Sepsis Study Group
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Whether past history of solid stage I/II inactive cancer has an impact on 28-day mortality of sepsis remains unclear. We aimed to determine the impact of history of stage I or II solid tumor malignancy in complete remission the la
Externí odkaz:
https://doaj.org/article/d49f138e25754267a170eb4aa2056d5a
Autor:
Evdoxia Kyriazopoulou, Konstantinos Leventogiannis, Anna Norrby-Teglund, Georgios Dimopoulos, Aikaterini Pantazi, Stylianos E. Orfanos, Nikoletta Rovina, Iraklis Tsangaris, Theologia Gkavogianni, Elektra Botsa, Eleftheria Chassiou, Anastasia Kotanidou, Christina Kontouli, Panagiotis Chaloulis, Dimitrios Velissaris, Athina Savva, Jonas-Sundén Cullberg, Karolina Akinosoglou, Charalambos Gogos, Apostolos Armaganidis, Evangelos J. Giamarellos-Bourboulis, on behalf of the Hellenic Sepsis Study Group
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Abstract Background A subanalysis of a randomized clinical trial indicated sepsis survival benefit from interleukin (IL)-1 blockade in patients with features of the macrophage activation-like syndrome (MALS). This study aimed to investigate the frequ
Externí odkaz:
https://doaj.org/article/0212585c0a184560bf60ae526a894911
Background: A subanalysis of a randomized clinical trial indicated sepsis survival benefit from interleukin (IL)-1 blockade in patients with features of the macrophage activation-like syndrome (MALS). This study aimed to investigate the frequency of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::daca4956a04fd0ce987a894b2692ac41
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108329
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108329
How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into spe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3a82ad04cb53c574eb8607bb950c2805
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108319
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108319
Controversies in outcomes with the parenteral administration of antioxidants as adjuvant therapies led to the measurement of malondialdehyde (MDA), a product of lipid peroxidation, in serum collected from 120 patients with primary Gram-negative bacte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a0a3bcb104fb06d260a3ab4152808ebb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108218
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108218
Introduction: Adenosine exerts anti-inflammatory and tissue-protective effects during systemic inflammation. While the tissue-protective effects might limit organ damage, its anti-inflammatory properties may induce immunoparalysis and impede bacteria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::28ae8735bca05a1617999e58c8ab2f2b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3125436
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3125436